2021. RFLSP.Russian.Finnish.Life.Science.Industry.EN

2.6 AVENA
Company profile
Avena company conducts research of properties of different
probiotics, mainly - bacterium Enterococcus faecium L3, and
realizes production of therapeutic and prophylactic products on
its basis. These products are aimed to restore natural human
microflora and help with dysbiosis and a huge list of diseases and
conditions, connected with it.
The science team of the company brings together microbiologists
and physicians under the guidance of corresponding member of
the Russian Academy of Sciences, Professor Alexander Suvorov.
The company also conducts clinical trials in leading clinics in St.
Petersburg and Moscow: North-Western State Medical University
named after I.I. Mechnikov, St. Petersburg State Pediatric Medical
University, The Pavlov First St. Petersburg State Medical
University, Scientific Research Institute of Nutrition, etc.
Products and services
The company produces original and generic drugs to combat the
following groups of diseases:
§ Gastroenterological diseases;
§ Infectious diseases;
§ Cancer and other diseases.
Key figures:
Founded: 13.12.2001
Turnover (2020): 2,534 mln. RUB
Employees (2020): 4
INN: 7802182990
Type of company: micro enterprise
Product code: 21.20.1 Manufacturing of
pharmaceuticals
Contact information:
Srednegavanskii pr., 3 flat 2
199106 St. Petersburg, Russia
+7 (812) 438 76 57
mail@avena.ru
https://avena.ru/
Contact person: Alekhina Galina – Director
94
RUSSIAN-FINNISH LIFE SCIENCE INDUSTRY
Research and export directory